美国非本土出生人群的COVID-19疫苗接种情况,2020-2022年
研究在美国明尼苏达州、科罗拉多州和宾夕法尼亚州的四个卫生系统计算2020年12月14日至2022年6月30日期间COVID-19疫苗基础系列启动、完成和第一剂加强针完成率,纳入1624573名符合基础系列接种条件患者和907749名符合加强针接种条件患者,发现非本土出生者和非英语偏好者加强针完成率较低。
要点
- 非本土出生者基础系列完成率72.7%高于美国出生者65.4%,但加强针完成率61.8%低于美国出生者70%。
- 难民加强针完成率46.7%低于非难民66.3%。
- 非英语偏好者加强针完成率55.3%低于英语偏好者67.3%。
核心结论
- 评估发现美国非本土出生者和非英语偏好人群的COVID-19疫苗接种率存在差异。
- 作者认为针对性外展工作可能有助于覆盖这些人群。
研究设计与样本
- 在明尼苏达州、科罗拉多州和宾夕法尼亚州的四个卫生系统计算COVID-19疫苗基础系列和加强针接种率。
- 纳入截至2022年1月1日年龄≥5岁且在2019年7月1日至2022年6月30日期间至少有一次初级保健就诊的患者。
- 纳入1624573名符合COVID-19基础系列疫苗条件的患者和907749名符合COVID-19加强针接种条件的患者。
主要发现
- 完成COVID-19基础系列的患者百分比(63.4%)和完成加强针的患者百分比(66.2%)相似。
- 基础系列完成率:非本土出生者72.7% vs 美国出生者65.4%。
- 基础系列完成率:难民63.5% vs 非难民63.4%。
- 基础系列完成率:非英语偏好患者62.7% vs 英语偏好患者63.6%。
- 加强针完成率:非本土出生者61.8% vs 美国出生者70%;难民46.7% vs 非难民66.3%;非英语偏好患者55.3% vs 英语偏好患者67.3%。
关键数值与推荐
- 基础系列完成率:非本土出生者72.7% vs 美国出生者65.4%。
- 加强针完成率:非本土出生者61.8% vs 美国出生者70%。
- 加强针完成率:难民46.7% vs 非难民66.3%。
- 加强针完成率:非英语偏好患者55.3% vs 英语偏好患者67.3%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In the United States (US), COVID-19 vaccination rates among non-US-born individuals (i.e., refugees, immigrants, and migrants [RIM]) are variable. Understanding baseline COVID-19 vaccine coverage among these populations and determining if disparities exist is essential for quality improvement initiatives and public health interventions. METHODS: Baseline COVID-19 vaccination rates for both primary series and booster doses were calculated at four health systems located in Minnesota, Colorado, and Pennsylvania participating in the Minnesota Department of Health's Center of Excellence in Newcomer Health. Patients aged ≥5 years as of 1/1/22, seen for ≥1 primary care visit during 7/1/2019-6/30/22 were included. Descriptive statistics were calculated for three measures of COVID-19 vaccine coverage during 12/14/2020-6/30/2022: 1) initiation of primary series; 2) completion of primary series; 3) completion of first booster. We calculated vaccine coverage rates for the entire population and stratified by subgroup including country of origin, refugee status, and primary language preference. RESULTS: We included 1,624,573 patients eligible for COVID-19 primary series vaccine and 907,749 eligible for COVID-19 booster vaccination. The percent of eligible patients who completed a COVID-19 primary series (63.4 %) and booster dose (66.2 %) were similar. Completion of the primary series was higher for non-US-born persons (72.7 %) compared with US born persons (65.4 %), similar among refugees (63.5 %) and non-refugees (63.4 %), and lower in patients with language preference other than English (62.7 %) compared with English preferring patients (63.6 %). Booster completion was lower for non-US-born persons (61.8 %), refugees (46.7 %), and patients with language preference other than English (55.3 %) compared with US-born (70 %), non-refugees (66.3 %), and English preferring patients (67.3 %) respectively. CONCLUSIONS: This evaluation identified disparities in COVID-19 vaccination rates among non-US-born persons and persons with a language preference other than English living in the US. Targeted outreach efforts may be beneficial in reaching these populations.
引用
- Nolan MB, Chrenka E, Walker P, et al. COVID-19 vaccine uptake among non-US-born populations in the United States, 2020-2022. Vaccine. 2024. PMID: 38604910. doi:10.1016/j.vaccine.2024.04.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。